Physician profile
Steven Patton
NPI 1194164749
$1,723.90
in general payments reported to CMS, 2019-2025
15 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $71.44 · 2022: $328 · 2023: $285 · 2024: $226 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $484.65 | 2019-2025 | Ozempic |
| Janssen Biotech, INC. | $239.40 | 2023 | Darzalex, Tecvayli, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $222.80 | 2024-2025 | |
| Lilly USA, LLC | $155.53 | 2019-2025 | Kisunla |
| Glaxosmithkline, LLC. | $133.49 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $124.99 | 2024 | Voquezna |
| Amgen INC. | $91.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.93 | 2019 | |
| Astellas Pharma US INC | $52.64 | 2019-2020 | |
| Medtronic, INC. | $45.84 | 2023 | Reveal Linq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.10 | 2019-2020 | |
| Sanofi Pasteur INC. | $24.30 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.68 | 2019 | |
| Pfizer INC. | $12.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.